Andreas Hammer

880 total citations · 1 hit paper
34 papers, 619 citations indexed

About

Andreas Hammer is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Andreas Hammer has authored 34 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Andreas Hammer's work include Atrial Fibrillation Management and Outcomes (9 papers), Heart Failure Treatment and Management (8 papers) and Diabetes Treatment and Management (6 papers). Andreas Hammer is often cited by papers focused on Atrial Fibrillation Management and Outcomes (9 papers), Heart Failure Treatment and Management (8 papers) and Diabetes Treatment and Management (6 papers). Andreas Hammer collaborates with scholars based in Austria, Germany and United States. Andreas Hammer's co-authors include Christoph E. Minder, Andreas E. Stuck, John C. Beck, Matthias Egger, Patrick Sulzgruber, Alexander Niessner, Lorenz Koller, Felix Hofer, Christian Hengstenberg and Günther Laufer and has published in prestigious journals such as JAMA, European Heart Journal and Thrombosis and Haemostasis.

In The Last Decade

Andreas Hammer

25 papers receiving 586 citations

Hit Papers

Home Visits to Prevent Nursing Home Admission and Functio... 2002 2026 2010 2018 2002 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Hammer Austria 7 320 270 144 112 97 34 619
Keith Nockels United Kingdom 7 263 0.8× 264 1.0× 74 0.5× 188 1.7× 21 0.2× 12 592
Sachin J. Shah United States 16 251 0.8× 55 0.2× 115 0.8× 119 1.1× 44 0.5× 55 757
Margaret E. Gatti United States 10 206 0.6× 172 0.6× 65 0.5× 67 0.6× 18 0.2× 11 951
Lynne Morishita United States 10 366 1.1× 233 0.9× 145 1.0× 128 1.1× 36 0.4× 17 585
Mélanie Le Berre Canada 10 205 0.6× 101 0.4× 87 0.6× 60 0.5× 24 0.2× 26 396
Manuj C. Weerasinghe Sri Lanka 11 136 0.4× 353 1.3× 33 0.2× 206 1.8× 55 0.6× 39 581
Ann E. Vandenberg United States 13 149 0.5× 111 0.4× 65 0.5× 65 0.6× 25 0.3× 35 490
Emma Regen United Kingdom 12 231 0.7× 170 0.6× 66 0.5× 85 0.8× 13 0.1× 23 448
Jennifer A. Ouellet United States 8 121 0.4× 104 0.4× 104 0.7× 103 0.9× 36 0.4× 13 368
Sei Lee United States 13 106 0.3× 97 0.4× 40 0.3× 44 0.4× 37 0.4× 26 485

Countries citing papers authored by Andreas Hammer

Since Specialization
Citations

This map shows the geographic impact of Andreas Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Hammer more than expected).

Fields of papers citing papers by Andreas Hammer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Hammer. The network helps show where Andreas Hammer may publish in the future.

Co-authorship network of co-authors of Andreas Hammer

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Hammer. A scholar is included among the top collaborators of Andreas Hammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Hammer. Andreas Hammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hammer, Andreas, Felix Hofer, Lorenz Koller, et al.. (2025). Mid-Regional Pro-Adrenomedullin Is Associated with Adverse Cardiovascular Outcomes After Cardiac Surgery. Journal of Personalized Medicine. 15(2). 47–47.
2.
Hammer, Andreas, Felix Hofer, Max Lenz, et al.. (2025). Beyond obesity: metabolic status as a key driver for cardiovascular outcomes in patients undergoing invasive coronary angiography. European Heart Journal - Quality of Care and Clinical Outcomes. 11(6). 825–834.
3.
Hammer, Andreas, Felix Hofer, Bernhard Frey, et al.. (2025). Drug-coated balloon vs drug-eluting stent in de novo coronary lesions: a propensity score matched cohort study. Clinical Research in Cardiology. 115(1). 60–68.
4.
Hammer, Andreas, Lorenz Koller, René Rettl, et al.. (2025). The Prognostic Interplay of Heart Failure and Chronic Kidney Disease in Atrial Fibrillation: Focus on Cardiorenal Outcomes. Cardiorenal Medicine. 15(1). 607–618.
5.
Hammer, Andreas, M Todorović, Walter Gall, et al.. (2024). Adherence to Secondary Prevention Measures after Acute Myocardial Infarction and Its Impact on Patient Outcome—A Nationwide Perspective. Journal of Clinical Medicine. 13(16). 4964–4964. 2 indexed citations
6.
Stojković, Stefan, Martin Riesenhuber, Andreas Hammer, et al.. (2024). Heart Failure with Preserved Ejection Fraction Correlates with Fibrotic Atrial Myopathy in Patients Undergoing Atrial Fibrillation Ablation. Journal of Clinical Medicine. 13(19). 5685–5685. 2 indexed citations
7.
Lee, Jong Min, Stefan Stojković, Martin Riesenhuber, et al.. (2024). Tricuspid regurgitation in atrial fibrillation: correlation to left atrial myopathy and improvement post ablation. European Heart Journal. 45(Supplement_1).
8.
Koller, Lorenz, Felix Hofer, Andreas Hammer, et al.. (2023). Soluble urokinase plasminogen activator receptor and survival in elective cardiac surgery. European Journal of Clinical Investigation. 53(5). e13953–e13953. 1 indexed citations
9.
Hammer, Andreas, Alexander Niessner, & Patrick Sulzgruber. (2023). Rivaroxaban in Valvular Atrial Fibrillation — a Critical Appraisal of the INVICTUS Trial. Cardiovascular Drugs and Therapy. 38(5). 1065–1067. 2 indexed citations
10.
Hammer, Andreas, Felix Hofer, Lorenz Koller, et al.. (2023). Sex-Related Disparities in Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Heart Failure. Journal of Women s Health. 32(11). 1219–1228. 4 indexed citations
11.
Hammer, Andreas, Mario Krammel, Sebastian Schnaubelt, et al.. (2023). The Impact of Preclinical High Potent P2Y12 Inhibitors on Decision Making at Discharge and Clinical Outcomes in Patients with Acute Coronary Syndrome. Journal of Clinical Medicine. 12(12). 4094–4094. 1 indexed citations
12.
Hammer, Andreas, Alexander Niessner, & Patrick Sulzgruber. (2023). Early Initiation of SGLT2 Inhibitors in Acute Heart Failure: a Focus on Diuresis and Renal Protection. Cardiovascular Drugs and Therapy. 39(3). 687–690. 2 indexed citations
13.
Hofer, Felix, Andreas Hammer, Lorenz Koller, et al.. (2023). Prescribing trends of sodium-glucose cotransporter 2 Inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction. European Heart Journal. 44(Supplement_2).
14.
Richter, Bernhard, Lorenz Koller, Felix Hofer, et al.. (2022). Galectin-3 is an independent predictor of postoperative atrial fibrillation and survival after elective cardiac surgery. Heart Rhythm. 19(11). 1774–1780. 8 indexed citations
15.
Hofer, Felix, Bernhard Richter, Patrick Sulzgruber, et al.. (2021). Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure. Cardiovascular Drugs and Therapy. 36(3). 497–504. 9 indexed citations
16.
Hammer, Andreas, Felix Hofer, Lorenz Koller, et al.. (2021). The Prognostic Impact of Anti-thrombotic Treatment Strategies After Biological Aortic Valve Replacement. Cardiovascular Drugs and Therapy. 36(6). 1137–1145.
17.
Schnaubelt, Sebastian, Lorenz Koller, Felix Hofer, et al.. (2021). The impact of invasive respiratory support on the development of postoperative atrial fibrillation following cardiac surgery. Journal of Clinical Anesthesia. 72. 110309–110309. 1 indexed citations
18.
Hofer, Felix, Andreas Hammer, Lorenz Koller, et al.. (2021). Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Coronary Artery Disease. Cardiovascular Drugs and Therapy. 35(6). 1161–1170. 6 indexed citations
19.
Schnaubelt, Sebastian, Andreas Hammer, Lorenz Koller, et al.. (2019). Meditation and Cardiovascular Health: What is the Link?. European Cardiology Review. 14(3). 161–164. 5 indexed citations
20.
Stuck, Andreas E., Matthias Egger, Andreas Hammer, Christoph E. Minder, & John C. Beck. (2002). Home Visits to Prevent Nursing Home Admission and Functional Decline in Elderly People. JAMA. 287(8). 1022–8. 512 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026